| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emmaus Life Sciences, Inc. (EMMA) has 0 insiders with recent SEC Form 4 filings, including 25 buys and 0 sells. EMMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2020 | Niihara Yutaka | Chairman And CEO | Buy | 4,900 | $1.48 | $7,252.00 | - | |
| Mar 18, 2020 | Lee Willis C | Vice Chairman &COO | Buy | 6,550 | $1.59 | $10,431.50 | +21.6% | |
| Mar 18, 2020 | Niihara Yutaka | Chairman And CEO | Buy | 7,200 | $1.54 | $11,097.00 | - | |
| Mar 13, 2020 | Niihara Yutaka | Chairman And CEO | Buy | 11,600 | $1.60 | $18,571.00 | - | |
| Mar 11, 2020 | Lee Willis C | Vice Chairman &COO | Buy | 2,500 | $1.68 | $4,204.00 | +10.6% | |
| Mar 10, 2020 | Niihara Yutaka | Chairman And CEO | Buy | 42,850 | $1.44 | $61,896.00 | +0.1% | |
| Mar 9, 2020 | Lee Willis C | Vice Chairman &COO | Buy | 11,150 | $1.37 | $15,312.00 | +675.8% | |
| Mar 5, 2020 | Niihara Yutaka | Chairman And CEO | Buy | 23,750 | $1.67 | $39,734.00 | - | |
| Feb 21, 2020 | Niihara Yutaka | Chairman And CEO | Buy | 48,000 | $1.80 | $86,580.00 | +0.2% | |
| Feb 18, 2020 | Niihara Yutaka | Chairman And CEO | Buy | 22,750 | $1.82 | $41,315.00 | - |